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ABSTRACT
Objective: Survey office-based obstetric-gynecologic practitioners regarding their knowledge of in-
fectious disease care and antibiotic use.
Methods: A survey questionnaire of multiple-choice questions was mailed to Fellows of the
American College of Obstetricians and Gynecologists about clinical entities for which recommen-
dations have undergone recent changes or about which there was a lack of consensus in a prior
similar survey (Gibbs RS, McGregor JA, Mead PB, et al.: Obstet Gynecol 83:631-636, 1994).
Results: Respondents indicated that oral metronidazole was their most frequent choice to treat
bacterial vaginosis. Ampicillin (57%) was used more often than penicillin (39%) for intrapartum
group B streptococcus prophylaxis. Azithromycin was preferred (61%) over erythromycin-base
(38%) for chlamydia treatment during pregnancy. There were several modes of practice that de-
viated from accepted care: 27% and 29% did not screen for chlamydia and gonorrhea, respectively,
in pregnancy; 17% used cultures for Gardnerella vaginalis to diagnose bacterial vaginosis; 25%
considered quinolones to be safe in pregnancy; 93% felt metronidazole should never be used in
pregnancy; and the majority (66%) would send a patient treated successfully for pelvic cellulitis
home with an oral antibiotic.
Conclusion: Respondents’ infectious disease knowledge and practices in obstetrics and gynecol-
ogy is appropriate in treating sexually transmitted diseases, bacterial vaginosis, and group B strep-
tococcus. Numerous deficiencies still exist in screening for sexually transmitted diseases in preg-
nancy and diagnosing bacterial vaginosis, as well as in the choice of antibiotics to use or avoid for
certain infections. Infect. Dis. Obstet. Gynecol. 6:247-251, 1998. (C) 1999 Wiley-Liss, Inc.
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eproductive tract infections and related condi-
,tions are among the most frequently seen clini-
cal entities in office-based obstetric and gyneco-
logic practice. Genital tract infections are a com-
mon complaint of patients seen in nonspecialized
office and clinic settings that have symptoms sug-
gesting genital infection, l’e
In 1994, Gibbs et al. published the results of our
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initial survey of infectious disease knowledge
among obstetricians and gynecologists. In that
study, we found that practice patterns were appro-
priate for antibiotic selection in the treatment of
sexually transmitted infections and postoperative
infections, universal screening for hepatitis B and
follow-up screening for hepatitis B in pregnancy,
and treatment of urinary tract infections in preg-
nancy. Obstetrician-gynecologists were less con-
sistent in the appropriateness of their practices
with regard to the management of ruptured mem-
branes and premature labor and universal screening
for group B streptococci (GBS). We also found in
the earlier study that there was a need for more
knowledge in the areas of managing perinatal viral
infections and the diagnosis and treatment of other
common sexually transmitted diseases (STDs). Be-
cause scientific and clinical knowledge regarding
infectious diseases is advancing rapidly, we have
taken the opportunity to update our prior survey,
focusing on both new knowledge and areas of prac-
tice.
METHODS
Questions were pretested for clarity. A total of
1,000 randomly selected American College of Ob-
stetricians and Gynecologists Fellows received the
questionnaires. Additionally, questionnaires were
mailed to 176 American College of Obstetricians
and Gynecologists Fellows who are members of the
Collaborative Ambulatory Research Network. The
Collaborative Ambulatory Research Network was
established in 1990 to facilitate the assessment of
prevailing patterns in obstetric-gynecologic clinical
practice and to help in the development of profes-
sional education where needed. The members of
the Collaborative Ambulatory Research Network,
who are a representative group of American Col-
lege of Obstetricians and Gynecologists Fellows,3
voluntarily participate in questionnaire studies
such as the present investigation. It should also be
noted that the physicians who participated in this
survey are practitioners, not research academicians.
Survey questions were primarily face-valid,
forced-choice questions pertaining to physicians’
screening and treatment practices and infectious
disease knowledge. In some instances, responses
followed a "check all that apply" format. Some
asked for a single response using a Leikert-type
scale. The questionnaire was divided into three
sections: 1) physician demographic information, 2)
practice and knowledge, and 3) perceived educa-
tional needs.
Data were analyzed using a personal computer-
based statistical software package, DOS 4.1 ver-
sion. Descriptive statistics were computed for the
measures used in the analyses. Group differences
in responses on continuous measures were assessed
using analysis of variance. All analyses were tested
for significance, using alpha 0.05. We used Bonfer-
roni’s tests to guard against alpha inflation. Addi-
tionally, data were analyzed for group differences
on questionnaire item responses, using a two-way
analysis of variance with sex (male vs. female) and
fellowship status (Collaborative Ambulatory Re-
search Network vs. non-Collaborative Ambulatory
Research Network) as between-subject factors. Be-
cause the knowledge base of recently-trained re-
spondents might contain more current information
or, conversely, because physicians trained less re-
cently may have more relevant clinical experience,
we examined two groups: those having completed
specialty training less than 15 years ago vs. 15 or
more years ago.
RESULTS
Data from respondents who returned the question-
naire within two months were included in the
analysis. Of the 176 questionnaires mailed to Col-
laborative Ambulatory Research Network Fellows,
69% were returned. Of the 1,000 mailed to non-
Collaborative Ambulatory Research Network Fel-
lows, 45% were returned. There was a significant
difference between Collaborative Ambulatory Re-
search Network Fellows and the control sample of
non-Collaborative Ambulatory Research Network
Fellows in the response rate (chi-square 19.52).
However, there were neither significant main ef-
fects nor interactions for sex, Collaborative Ambu-
latory Research Network membership, fellowship
status, or length of time since training. The re-
sponses were collapsed across factors in subsequent
analyses.
Fifty-seven percent of all respondents were
men, and 43% were women. Fifty-six percent de-
scribed themselves as primary care physicians, and
44% as specialists. Most described their practice
focus as general obstetrics and gynecology (81%).
Thirty-seven percent indicated they practiced in
an obstetric-gynecologic partnership, 38% prac-
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ticed in an urban setting, and 32% in a suburban
setting. Respondents’ average age was 42.19 years,
and they completed their specialty training an av-
erage of 10.9 years ago.
Pregnant Women
Respondents reported screening for human immu-
nodeficienc virus (HIV, 88%), chlamydia (73%),
gonorrhea (71%), and bacterial vaginosis (37%) dur-
ing antenatal care. If a pregnant woman were ex-
posed directly to cytomegalovirus in the "first half of
her pregnancy, 53% of respondents said they would
provide counseling, perform serologic studies, and
perform amniocentesis if seroconversion occurred.
Thirty-six percent implied they would refer the
woman for consultation.
When asked which antimicrobials are contrain-
dicated for use during pregnancy, 75% cited ofloxa-
cin. Conversely, 25% considered quinolones safe
for use. Respondents felt that cefoxitin (99%), am-
picillin (97%), and vancomycin (83%) were gener-
ally safe for indicated infections during pregnancy.
When asked to select the drug of choice for
treating Chlamydia trachomatis in pregnancy, most
respondents chose single-dose azithromycin (61%),
followed by multi-dose erythromycin base (38%).
At the time of this survey, the Centers for Disease
Control and Prevention’s (CDC) 1998 Guidelinesfor
Treatment of Sexually Transmitted Diseases were not
published.
4 Regarding the prescription of oral met-
ronidazole during each trimester of pregnancy, 93%
of respondents said they never prescribe metroni-
dazole during pregnancy. Among the 7% who said
they do prescribe metronidazole during pregnancy,
79% said they did not prescribe oral metronidazole
for use in the first trimester; 69% prescribed it for
use in the second trimester, and 96% prescribed it
for use in the third trimester.
When caring for pregnant women, 36% reported
that they screen for bacterial vaginosis at the first
visit, 2% at 20 weeks of gestation, 6% at 28 weeks,
and 8% at 35 weeks. Fifty-seven percent screen
only women who are symptomatic, and 11% do not
screen for bacterial vaginosis at all. In diagnosing
bacterial vaginosis, 93% used the presence of "clue
cells" to make the diagnosis; 78%, amine odor with
potassium hydroxide; 59%, milky discharge; and
48%, elevated vaginal pH. Culture for Gardnerella
vaginalis is still used by 18% of respondents. Bac-
terial vaginosis was described as the most common
type of vaginitis (P 0.001). In counseling HIV-
infected women during pregnancy, 79% of respon-
dents said they discuss safe sex practices, 76% pro-
vided HIV pharmacological treatments, 74% pro-
vided contraceptive counseling, 65% discussed the
avoidance of breast feeding, and 65% promoted
and identified treatment for other family members.
Respondents reported screening 20-year-old
women at the initial prenatal visit, regardless of
symptoms or marital status, for reproductive infec-
tions, including HIV (86%), chlamydia (73%), gon-
orrhea (71%), syphilis (94%), hepatitis B (93%),
bacterial vaginosis (37%), and trichomoniasis
(28%). Respondents then were asked about screen-
ing for reproductive tract infections in asymptom-
atic women, regardless of age or marital status, at
the first prenatal visit. The results indicate that
87% screened for HIV, 73% for chlamydia, 71% for
gonorrhea, 95% for syphilis, 93% for hepatitis B,
29% for bacterial vaginosis, and 29% for trichomo-
niasis.
Nonpregnant Women
In response to the question of which strategy was
used with regard to sex partners of female patients
with C. trachomatis genital infection, it was noted
that 31% of the responding practitioners write a
prescription for the partner, 30% refer the partner
to a public health clinic, 24% refer the partner to a
primary care physician, and 11% prescribe double
antibiotic doses for use by both the patient and her
partner.
Most physicians felt either very confident (52%)
or completely confident (35%) in their ability to
diagnose common causes of vaginitis. The remain-
ing 13% revealed a lack of confidence in their abil-
ity to diagnose an infectious cause of vaginitis.
With regard to the treatment of choice for bacterial
vaginosis in a 30-year-old, nonpregnant woman,
most practitioners surveyed (51%) chose to pre-
scribe a regimen of 500 mg metronidazole, orally,
twice a day for seven days, followed by 0.75% met-
ronidazole vaginal gel (36%); 12% indicated they
prescribe clindamycin vaginal cream.
For treating C. trachomatis in nonpregnant
women, the drugs of choice were doxycycline (by
53%) and azithromycin (by 43%). The antimicro-
bial treatments of choice for symptomatic lower
urinary tract infections in nonpregnant women
were sulfamethoxazole-trimethoprim (50%) and ni-
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trofurantoin (40%). For uncomplicated cystitis in a
25-year-old gynecologic patient, the preferred du-
ration of therapy was three days (42%) or seven
days (41%). Single-dose treatment was favored by
17% of respondents.
Physicians reported their primary antibiotic regi-
men for treating pelvic inflammatory disease (PID)
is cefoxitin or intramuscular cefotetan plus oral
doxycycline (54%), followed by ofloxacin com-
bined with a single dose of azithromycin (16%).
Other regimens used to a lesser degre include oral
doxycycline (8%), ofloxacin or levofloxacin com-
bined with metronidazole (6%), ofloxacin com-
bined with single-dose azithromycin (5%), ofloxa-
cin or oral levofloxacin (4%), oral azithromycin
(3%), azithromycin and oral metronidazole (3%),
and oral ampicillin (1%). When asked what is the
appropriate indication for imipenem/ci,lastatin, the
great majority (85%) selected the response "serious
infection with suspected nosocomial organism."
When asked which infectious diseases they would
treat with a 1-g dose of azithromycin, 93% re-
sponded urogenital chlamydia infection. Con-
versely, 80% indicated they would not use such a
dose to treat gonorrhea, 97% would not use it to
treat urinary tract infections, and 99% would not
use it to treat pseudomembranous colitis. When
asked about the use of oral antibiotics after suc-
cessful parenteral therapy for postoperative cuff
cellulitis, most respondents (66%) indicated they
would send their patients home with a prescription
for seven days’ worth of oral antibiotics. The re-
maining 24% indicated they would discharge a pa-
tient with no oral antibiotic therapy.
EDUCATION
When asked specifically how they would like to
learn more about reproductive tract infections, over
half (52%) of respondents cited continuing medical
education programs as their preferred source of in-
formation. Grand rounds were preferred by 38% of
respondents, followed by computer-based Internet
resources (25%), and contact with pharmaceutical
representatives (21%).
DISCUSSION
We surveyed obstetricians’ and gynecologists’
clinical knowledge and practices regarding com-
mon infection-related clinical entities and antibiot-
ic choices. As in a prior study, the respondents gen-
erally demonstrated knowledgeable and well-
founded clinical approaches, especially in regard to
diagnosis and treatment of STDs, including HIV,
in both pregnant and nonpregnant women. On the
other hand, sizable numbers of practitioners per-
sisted in practices that are unsupported in the lit-
erature, including 1) use of G. vaginalis cultures to
diagnose bacterial vaginosis, and 2) discharging pa-
tients with satisfactorily treated posthysterectomy
cuff cellulitis with a prescription for oral antibiotics.
The questionnaire also detailed current practice
patterns among respondents, which will be of in-
terest to policymakers and authoritative organiza-
tions. Most respondents prefer using a culture-
based approach rather than intrapartum risk-
indicated chemoprophylaxis to prevent early onset
GBS sepsis in newborns. Most physicians preferred
the more broad-spectrum ampicillin intrapartum
treatment to prevent GBS neonatal sepsis rather
than the more narrowly-focused penicillin intrapar-
tum chemoprophylaxis, even though penicillin is
recommended by the CDC and the American Col-
lege of Obstetricians and Gynecologists. s,6 The
choice of antibiotic in this clinical situation is an
empirical one. Ampicillin is more broad spectrum,
but some fear the growth of resistant facultative,
gram-negative bacilli in neonates when this agent
is used. Others feel the broader coverage offers
advantages in eradicating pathogens other than
GBS. Otherwise, in this study the CDC patterns
were followed regarding antibiotic choices.
Azithromycin was preferred over erythromycin
for treatment of chlamydial infections during preg-
nancy. On the other hand, most physicians use an
inexpensive, multi-dose doxycycline regimen over
a single-dose azithromycin for chlamydia treatment
in nonpregnant women and their partners. Inter-
estingly, most study participants indicated they
routinely indirectly treat or refer contacts ofwomen
with chlamydial genital infections. If true, this ap-
pears to be a change from past practices and may
have been influenced by a greater understanding of
STDs and their physical, psychological, and eco-
nomic consequences for patients, providers, and
payers. 7 Indirect treatment could include seeing
and treating the partner or contact, writing a pre-
scription for a partner without seeing him, or writ-
ing a prescription with a refill to the female in-
structing her to give the refill to her partner. If
physicians are treating the partner of their patient
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without seeing them, is this ethically sound? This
issue must be addressed with the development of
public health or professional practice guidelines.
Variations in responses regarding some entities
and practices show the need for ongoing continuing
medical education and promulgation of guidelines
to translate present knowledge into everyday prac-
tice. Fully 25% of respondents considered a quino-
lone antibiotic as useful during pregnancy, al-
though quinolones are contraindicated in preg-
nancy because of their effect on the fetal skeletal
system.
8 Also, 17% still employ culture for G. vagi-
halls as a means to diagnose bacterial vaginosis,
when this has been shown not to be a reliable
means of diagnosing this disorder.8 Sixty-six per-
cent of respondents would send a patient success-
fully treated for a postoperative cuff infection
home with a prescription for oral antibiotics, in
spite of data that indicate this is not necessary.
9
Large numbers of obstetrician-gynecologists do not
prescribe metronidazole in pregnancy, even though
no data exist to show damaging effects on neo-
nates. 1,11 These findings indicate a need for fo-
cused continuing professional education to correct
these deficiencies.
We have identified the following areas as ones
that need to be addressed more effectively: 1) the
inefficacy of cultures to diagnose bacterial vagino-
sis; 2) the effects of viral infections in pregnancy
and how to screen and counsel pregnant women, 3)
how to treat and manage the partners of STD-
infected patients; and 4) the safety and use of an-
tibiotics in pregnancy, including azithromycin, qui-
nolones, and metronidazole.
We conclude the following improvements in
practice have occurred since the first survey: 1)
screening for STDs in pregnancy; 2) use of GBS
screening and prophylaxis; 3) referral or treatment
of partners of STD-infected patients; 4) agreement
with CDC guidelines in treatment regimens for
STDs surveyed and PID; and 5) HIV counseling.
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